Abstract. This minireview describes the practical use of assay systems to detect nitric oxide (NO) by electron paramagnetic resonance (EPR) spectroscopy for evaluation of endothelial functions. The iron(II)-dithiocarbamate complexes, such as iron(II)-(N-methyl-D-glucamine dithiocarbamate), are commonly used in EPR detection of NO both in vivo and in vitro. However, due to their redox activity, these complexes have some drawbacks that limit their usefulness for the detection of NO. On the other hand, the measurement of hemoglobin-NO adduct (HbNO) in whole blood by the EPR method seems relevant for the assessment of systemic NO levels. However, ceruloplasmin and an unknown radical species overlapping the same magnetic field as that of HbNO, which makes it physically impossible to measure small amounts of HbNO. Thus, to reveal the EPR spectrum of HbNO, we developed the EPR signal subtraction method, which is based on the computer-assisted subtraction of the digitized EPR spectrum of HbNO-depleted blood from that of the sample blood using software. Using this technique, we succeeded in measuring the steady blood HbNO level as an index of NO by the EPR HbNO signal subtraction method. We also demonstrated that temocapril reduces abnormalities of NO dynamics in the L-NAME (N w -nitro-L-arginine-methylester)-induced endothelial dysfunction of rats using the EPR HbNO signal subtraction method.
Introduction
Nitric oxide (NO), a free radical molecule, has numerous roles in various physiological functions, such as the regulation of blood pressure (1) , immune response to bacterial infection (2, 3) , and nervous systems (4) .
In order to understand the mechanisms by which NO acts, accurate methods are required for its determination. Several methods for the quantitation of NO such as chemiluminescence (5) , methemoglobin formation (6) , and electron paramagnetic resonance (EPR) spectroscopy of nitrosyl-metal complexes (7) have been developed (8) . The Griess and cGMP methods have been widely used to measure NO production in vivo (9, 10) and in vitro (11, 12) , but these values do not always reflect the concentration of NO, because of their poor specificities for blood NO. EPR spectroscopy is a technique used for the detection and measurement of free radical species. EPR methods using endogenous and exogenous spin trapping agents, which stabilize NO as a polyatomic spin adduct, have been developed (13 -17) .
NO is reported to react rapidly with heme proteins (18 -21) . In the circulatory system, NO exists as a relatively stable hemoglobin-NO adduct (HbNO) (22) with a half-life of 21 min in fully functional erythrocytes (23) , which means that the amount of HbNO may reflect the blood NO concentration.
Hb is also known to bind to NO, resulting in the formation of HbNO that has a characteristic EPR spectrum and hence is used as a spin trapping agent for NO in lipopolysaccharide (LPS)-treated (24, 25) and NO donor-administered (26, 27) animals. In addition, the HbNO signal has reportedly been successfully detected in untreated animals and human blood using the EPR method (28 -32) . However, there were still some difficulties in obtaining a fine HbNO signal because of existing paramagnetic compounds that give a strong EPR signal overlapping the same region as HbNO (26, 33 -37) . To overcome the difficulties mentioned above, we developed the EPR signal subtraction method, which is based on the subtraction of the EPR spectrum of HbNO-depleted whole blood from that of each sample. This minireview describes the practical use of assay systems for the detection of NO by the EPR subtraction method for evaluation of endothelial functions.
Iron dithiocarbamate as spin trap for no detection
Various iron-dithiocarbamate complexes are known to bind NO. This property has been used for detection of NO both in vivo and in vitro. The diethyl dithiocarbamate (DETC)-ferrous complex is a commonly used spin trap agent for NO (38) , resulting in the formation of the (DETC) 2 -Fe
2+
-NO complex, which has a characteristic triplet EPR signal. Although the (DETC) 2 -Fe 2+ complex has been widely used to trap NO from cells and tissues (39, 40) , quantification of NO using the (DETC) 2 -Fe 2+ complex requires complicated procedures to overcome its low solubility in water (41) . N-Methyl-D-glucamine dithiocarbamate (MGD) was used to overcome the poor solubility of the (DETC) 2 -Fe 2+ complex. The (MGD) 2 -Fe 2+ complex is water-soluble (42) and forms the characteristic triplet EPR spectrum after trapping NO.
Although it is widely assumed that dithiocarbamateFe 2+ complexes specifically react with NO to form dithiocarbamate-Fe 2+ -NO complexes, the coexistence of dithiocarbamate-Fe 2+ complexes and nitrite produces a triplet EPR spectrum, which corresponds to that of the dithiocarbamate-Fe
-NO complex even at physiological pH (43) . We investigated the pathway of NO production from nitrite by the (MGD) 2 -Fe 2+ complex under anaerobic conditions at physiological pH (44) , and found that physiological concentrations of glutathione (GSH) (approx. 5 mM) and L-cysteine (approx. 0.5 mM) accelerated the formation of the (MGD) 2 Fe 2+ -NO complex from nitrite (45) . In addition, we found that air oxidation of the (MGD) 2 Fe 2+ complex results in the formation of the (MGD) 3 Fe 3+ complex, presumably concomitantly with reactive oxygen species (ROS) (46) . Thiol compounds such as GSH and L-cysteine enhance the formation of ROS by the (MGD) 2 Fe 2+ complex by accelerating its redox turnover at moderate rate con- (45, 47) . These phenomena elucidate the difficulties in utilization of iron-dithiocarbamates for detection of NO. One should carefully consider its diverse reaction properties. As shown in Fig. 1 , which of these reactions will dominate in vivo will depends, to a large extent, on the relative concentrations of thiol compounds, molecular oxygen, nitrite, S-nitrosothiol, and NO as well as the various reaction rates of the iron-MGD complex. In any case, special attention to these facts is needed to interpret the detection of the EPR signal of the (MGD) 2 Fe 2+ -NO complex from biological samples containing thiol compounds, nitrite, and / or S-nitrosothiols.
HbNO as an index of no formation in vivo
Recently, it was reported that endothelium-derived NO diffuses into blood and permeates the erythrocyte membrane and then binds to hemoglobin to form the relatively stable HbNO in erythrocytes (48) , which means that the amount of HbNO may reflect the blood NO concentration. HbNO has a characteristic EPR spectrum, and hence endogenous Hb acts as a spin trapping agent for NO in LPS-treated (24, 25) and NO donor-administered (26, 27) animals. In addition, the HbNO signal has been successfully detected in untreated animals and human blood using the EPR method (12, 28, 29, 31) . However, there were still some difficulties in obtaining a fine HbNO signal because of the existence of paramagnetic compounds that give a strong EPR signal overlapping the same region to HbNO (26, 33 -37) . Therefore, we developed an improved method of detecting this HbNO signal in whole blood by EPR spectroscopy. To overcome the difficulties mentioned above, we developed the EPR subtraction method, which is based on the subtraction of the EPR spectrum of HbNO-depleted whole blood from that of each sample.
Practical application of EPR subtraction method for HbNO quantitation in rats
Preparation of HbNO-depleted whole blood First, we produced NO-depleted venous blood. NNitro-L-arginine-methylester (L-NAME) is a non-selective NOS inhibitor (49 -51) commonly used both in vivo (52, 53) and in vitro (54, 55) , and chronic L-NAME (0.5 -1.0 g/ L)-treated rats have been widely used as a model of NO deficiency (56 -58) . To produce NOdepleted rats, we administered tap water containing L-NAME (1 g / L) for 1 week. Rats were sacrificed, and venous blood was taken from the vena cava with a 1-ml plastic syringe and stored in liquid nitrogen until use.
EPR measurement and data processing
EPR measurements were carried out in liquid nitrogen. The frozen sample was directly transferred into a liquid nitrogen-filled quartz finger dewer, which was placed in the cavity of the EPR measurement device. A JES TE-300 ESR spectrometer (JEOL Co., Ltd., Tokyo) with an ES-UCX2 cavity (JEOL Co.) was utilized to collect EPR spectra at the X-band (9.5 GHz). Each sample was measured four times and normalized using the software ESPRIT 432 (JEOL Co.) in order to improve the signal / noise ratio. Typical EPR conditions were as follows: power, 20 mW; modulation amplitude, 9.045 GHz; field, 3200 ± 250 gauss; modulation width, 6.3 gauss; sweep time, 60 min; time constant, 1 s; and amplitude, 250. Spectra were stored on an IBM PC for analysis.
The principle of the EPR signal subtraction method of HbNO is to give the EPR signal of HbNO prominence by subtraction of the NO-depleted EPR signal from the objective one (59, 60) . This manipulation is accomplished using the special software EPRMAIN, which was obtained from the National Institute of the Environmental Health Sciences (NIEHS) (http://epr. niehs.nih.gov / pest.html).
Typical EPR spectra obtained from venous whole blood of untreated and L-NAME-treated NO-depleted rats are shown in Fig. 2, A and B, respectively. Figure 2C is the differential EPR spectra obtained by subtracting the spectrum of Fig. 2A from that of Fig. 2B using EPRMAIN, and Fig. 2D is the authentic EPR signal of HbNO. We can see no difference between Fig. 2A and Fig. 2B . However, it shows a weak but distinct triplet hyperfine structure with a coupling constant of 17.5 gauss in Fig. 2C , and this EPR signal was assigned to HbNO (Fig. 2D) (35, 37) . A calibration curve was obtained using the height of the left line of a 5-coordinate a -nitrosyl hene-derived triplet signal (Fig. 2E) , and the intensity of the EPR signal linearly increased according to the increased NO concentration with the correlation coefficient r 2 = 0.995 (Fig. 2F) . Application of an EPR-subtraction method to HbNO quantitation HbNO production by L-arginine infusion: L-Arginine is a physiological precursor of NO production. NO is synthesized from the terminal guanidine group of Larginine by NOS (61, 62) . To determine whether the EPR signal of HbNO is derived from L-arginine-dependent NO or not, we infused L-and D-arginine into rats via the femoral vein and measured the EPR signal of HbNO using the EPR-subtraction method. In the case of L-arginine, the HbNO concentration was increased with the increment of administered L-arginine, whereas D-arginine did not modify the HbNO (63) . These results imply that the EPR signal for HbNO reflects the endogenous changes in NO dynamics.
Effect of temocapril on NO dynamics in the L-NAMEinduced endothelial dysfunction rats ( Fig. 3) : Angiotensin-converting enzyme inhibitors (ACEIs) have been shown to significantly ameliorate endothelial dysfunction and structural changes of some organs in experimental and clinical studies (64 -69) . It seems conceivable that the improvement of endothelial function caused by ACEIs may result from the restoration of blood NO levels. To examine this hypothesis, we used chronic L-NAME-treated rats as an animal model of endothelial dysfunction and examined the effect of temocapril (70, 71) on the level of HbNO as an index of NO. The oral administration of L-NAME (1 g / L, in drinking water for 2 weeks) induced hypertension (SBP: 150 ± 5 mmHg) with reduction of HbNO concentration (4.4 ± 0.7 m M, 40% of the control), but the administration of temocapril dose-dependently attenuated hypertension (2 mg temocapril / kg per day, 135 ± 5 mmHg; 20 mg temocapril / kg per day, 125 ± 5 mmHg) and restored the HbNO level (2 mg temocapril / kg per day, 5.7 ± 0.5 m M; 20 mg temocapril / kg per day, 7.0 ± 0.8 mM). Although the exact mechanism by which temocapril improves NO dynamics is still unclear, our EPR-subtraction technique first demonstrated that temocapril reversed the decrease of blood NO in L-NAME-treated rats.
Concluding remarks
There are two major spin-trapping agents for detection of systemic NO using EPR spectroscopy. One is iron-dithiocarbamate complexes and the other is hemoglobin. The former compounds have some problems, and one should carefully consider its diverse reactions (72, 73) . The latter technique, which is described in this review, is specific for NO and does not require any pretreatment. Hence it seems simple and relevant as a method for measurement of the NO concentration in blood, but at the same time, we recognize some limitations of our method. The detection limit of HbNO is in the m M range with the present equipment. Further improvements will be required to apply this technique for clinical use. Fig. 3 . Effect of chronic L-NAME treatment in combination with temocapril on HbNO concentration. L-NAME treatment (1 g/L L-NAME in drinking water for 14 days) significantly reduced the blood HbNO concentration from 10.1 ± 2.0 m M (control) to 4.4 ± 0.7 m M (A). However, co-administration of temocapril restored the L-NAME-induced HbNO reduction in a dose-dependent manner (B: 2 mg temocapril /kg per day, 5.7 ± 0.5 HbNO mM; C: 20 mg temocapril /kg per day, 7.0 ± 0.8 HbNO mM). *P<0.05 (Bonferroni test). Modified from Ref. 63 .
